Published in Genome Med on June 08, 2011
The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38
Through a glass darkly: seeking clarity in preventing late kidney transplant failure. J Am Soc Nephrol (2014) 1.07
Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics (2013) 0.90
Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int (2012) 0.85
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest (2017) 0.83
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches. Semin Immunol (2013) 0.80
Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials. Clin Transl Med (2014) 0.79
Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation. PLoS One (2017) 0.78
Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation. PLoS One (2013) 0.78
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplant Direct (2016) 0.77
CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model. Exp Ther Med (2014) 0.77
Computational Models for Transplant Biomarker Discovery. Front Immunol (2015) 0.77
Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis (2017) 0.75
Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation. Clin Epigenetics (2016) 0.75
Advances in diagnostics for transplant rejection. Expert Rev Mol Diagn (2016) 0.75
Genomics of liver transplant injury and regeneration. Transplant Rev (Orlando) (2014) 0.75
Peak Serum AST Is a Better Predictor of Acute Liver Graft Injury after Liver Transplantation When Adjusted for Donor/Recipient BSA Size Mismatch (ASTi). J Transplant (2014) 0.75
Global functional profiling of gene expression. Genomics (2003) 12.05
Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res (2003) 9.30
A systems biology approach for pathway level analysis. Genome Res (2007) 6.95
Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30
A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Babel's tower revisited: a universal resource for cross-referencing across annotation databases. Bioinformatics (2006) 2.78
NetPath: a public resource of curated signal transduction pathways. Genome Biol (2010) 2.62
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
Spermatozoal RNA profiles of normal fertile men. Lancet (2002) 2.46
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46
Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00
Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol (2009) 1.86
Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68
Assessing the functional bias of commercial microarrays using the onto-compare database. Biotechniques (2003) 1.52
Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant (2003) 1.48
Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med (2013) 1.47
Transcriptional Perturbations in Graft Rejection. Transplantation (2015) 1.40
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling. Kidney Int (2005) 1.31
Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol (2010) 1.27
Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl (2010) 1.20
Characterization of intra-graft B cells during renal allograft rejection. Kidney Int (2008) 1.17
Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol (2009) 1.16
Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol (2012) 1.05
Predicting novel human gene ontology annotations using semantic analysis. IEEE/ACM Trans Comput Biol Bioinform (2010) 1.04
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation (2003) 1.04
Pediatric renal transplantation: an overview and update. Curr Opin Pediatr (2010) 1.02
Molecular diagnostics in transplantation. Nat Rev Nephrol (2010) 1.01
The proteogenomic path towards biomarker discovery. Pediatr Transplant (2008) 1.00
Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants. BMC Bioinformatics (2010) 0.99
Pediatric kidney transplantation. Pediatr Clin North Am (2010) 0.98
Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant (2003) 0.98
Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant (2007) 0.97
BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection. Transplantation (2009) 0.96
A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol (2006) 0.96
Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol (2005) 0.96
A rapid noninvasive assay for the detection of renal transplant injury. Transplantation (2013) 0.93
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol Commun (2014) 0.93
Differential immunogenicity and clinical relevance of kidney compartment specific antigens after renal transplantation. J Proteome Res (2010) 0.92
Combined liver-kidney transplantation in children: indications and outcome. Pediatr Transplant (2008) 0.92
Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation (2010) 0.91
Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res (2012) 0.91
Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease. Mol Cell Proteomics (2010) 0.91
The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) (2010) 0.90
The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol (2013) 0.89
The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics. Mol Cell Proteomics (2013) 0.89
Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy. Transplantation (2009) 0.88
The dual role of epithelial-to-mesenchymal transition in chronic allograft injury in pediatric renal transplantation. Transplantation (2011) 0.88
Using gene arrays in diagnosis of rejection. Curr Opin Organ Transplant (2009) 0.87
Protein and peptide biomarkers in organ transplantation. Biomark Med (2012) 0.87
Optimization for peptide sample preparation for urine peptidomics. Clin Proteomics (2014) 0.87
Microarrays: a monitoring tool for transplant patients? Transpl Int (2006) 0.86
Mycophenolate mofetil in pediatric renal transplantation. Transplantation (2005) 0.85
Profiling the proteome in renal transplantation. Proteomics Clin Appl (2011) 0.85
Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis. J Inherit Metab Dis (2010) 0.85
Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation (2010) 0.85
Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol (2005) 0.84
A microarray analysis of the effects of moderate hypothermia and rewarming on gene expression by human hepatocytes (HepG2). Cell Stress Chaperones (2010) 0.84
Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients. Transplantation (2011) 0.84
Arraying the orchestration of allograft pathology. Am J Transplant (2004) 0.84
Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis (2013) 0.84
Moving beyond HLA: a review of nHLA antibodies in organ transplantation. Hum Immunol (2013) 0.83
Microarrays: monitoring for transplant tolerance and mechanistic insights. Clin Lab Med (2008) 0.83
Caspase-4 may play a role in loss of proximal tubules and renal injury in nephropathic cystinosis. Pediatr Nephrol (2010) 0.83
Abnormal mitochondrial autophagy in nephropathic cystinosis. Autophagy (2010) 0.83
Transplantomics and biomarkers in organ transplantation: a report from the first international conference. Transplantation (2011) 0.82
Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation (2010) 0.82
Significance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrate. PLoS One (2013) 0.82
Interpreting the proteome and peptidome in transplantation. Adv Clin Chem (2009) 0.81
Cell-free DNA as a measure of transplant injury. Clin Transpl (2012) 0.81
Harnessing the diversity of the human T-cell repertoire: a monitoring tool for transplantation tolerance? Eur J Immunol (2010) 0.81
Microarrays: new tools for transplantation research. Pediatr Nephrol (2003) 0.81
Corticosteroid avoidance in pediatric renal transplantation: can it be achieved? Paediatr Drugs (2004) 0.80
Microangiopathy of brain, retina, and inner ear (Susac's syndrome) in an adolescent female presenting as acute disseminated encephalomyelitis. Pediatrics (2004) 0.80
Generalizable Biomarkers in Critical Care: Toward Precision Medicine. Crit Care Med (2017) 0.79
Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach. Clin J Am Soc Nephrol (2011) 0.79
Renal transplantation in children with thrombosis of the inferior vena cava requires careful assessment and planning. Pediatr Nephrol (2008) 0.78
Recent advances in biomarker discovery in solid organ transplant by proteomics. Expert Rev Proteomics (2011) 0.78
Steroid minimization for sirolimus-treated renal transplant recipients. Clin Transplant (2010) 0.78
Option of pre-emptive nephrectomy and renal transplantation for Bartter's syndrome. Pediatr Transplant (2006) 0.78
Standardizing resistive indices in healthy pediatric transplant recipients of adult-sized kidneys. Pediatr Transplant (2009) 0.77
Transplant reno-vascular stenoses associated with early erythropoietin use. Clin Transplant (2007) 0.77
Benchmarking Sepsis Gene Expression Diagnostics Using Public Data. Crit Care Med (2016) 0.76
Self-antigens and rejection: a proteomic analysis. Curr Opin Organ Transplant (2016) 0.76
Extended daclizumab monotherapy for rejection-free survival in non-adherent adolescent recipients of renal allografts. Pediatr Transplant (2008) 0.76
Microarrays: interrogating the transplant transcriptosome. Clin Transpl (2004) 0.76
The pits and pearls in translating operational tolerance biomarkers into clinical practice. Curr Opin Organ Transplant (2012) 0.76
The bumpy road of genomic medicine in transplantation: lessons from studies on calcineurin inhibitor nephrotoxicity. Transplantation (2012) 0.76
The coin toss of B cells in rejection and tolerance: danger versus defense. Semin Immunol (2011) 0.75
Monitoring calcineurin inhibitor therapy: localizing the moving target. Transplantation (2010) 0.75
C3 polymorphisms and outcomes of renal allografts. N Engl J Med (2009) 0.75
META-ANALYSIS OF CONTINUOUS PHENOTYPES IDENTIFIES A GENE SIGNATURE THAT CORRELATES WITH COPD DISEASE STATUS. Pac Symp Biocomput (2016) 0.75